|
GB9801398D0
(en)
|
1998-01-22 |
1998-03-18 |
Anggard Erik E |
Chemical compounds
|
|
IT1301759B1
(it)
*
|
1998-06-19 |
2000-07-07 |
Nicox Sa |
Sali nitrati di farmaci antiipertensivi
|
|
IT1311923B1
(it)
|
1999-04-13 |
2002-03-20 |
Nicox Sa |
Composti farmaceutici.
|
|
IE20000052A1
(en)
*
|
1999-04-29 |
2000-11-29 |
Russinsky Ltd |
Nitric acid salts of B-blockers
|
|
IT1314184B1
(it)
*
|
1999-08-12 |
2002-12-06 |
Nicox Sa |
Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
|
|
AU7365900A
(en)
|
1999-09-08 |
2001-04-10 |
Nitromed, Inc. |
Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
|
|
US7708989B2
(en)
|
1999-10-29 |
2010-05-04 |
Nitromed, Inc. |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
US7537785B2
(en)
*
|
1999-10-29 |
2009-05-26 |
Nitromed, Inc. |
Composition for treating vascular diseases characterized by nitric oxide insufficiency
|
|
US6635273B1
(en)
|
1999-10-29 |
2003-10-21 |
Trustees Of Boston University |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
US7235237B2
(en)
|
1999-10-29 |
2007-06-26 |
Nitromed, Inc. |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
CA2393724A1
(en)
*
|
1999-12-23 |
2001-06-28 |
Nitromed, Inc. |
Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
|
|
WO2001061043A2
(en)
|
2000-02-16 |
2001-08-23 |
Illumina, Inc. |
Parallel genotyping of multiple patient samples
|
|
CA2410632A1
(en)
|
2000-06-22 |
2001-12-27 |
David S. Garvey |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
AU5939901A
(en)
*
|
2000-10-27 |
2002-05-06 |
Nitromed Inc |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
EP1219306A1
(en)
|
2000-12-29 |
2002-07-03 |
Nicox S.A. |
Compositions comprising cyclodextrins and NO- releasing drugs
|
|
CA2446064A1
(en)
|
2001-05-02 |
2002-11-07 |
Nitromed, Inc. |
Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
|
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
|
US7011854B2
(en)
|
2002-02-04 |
2006-03-14 |
Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
|
|
US7968605B2
(en)
*
|
2002-02-04 |
2011-06-28 |
ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
|
US20080026984A1
(en)
*
|
2002-02-04 |
2008-01-31 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
|
US7499806B2
(en)
|
2002-02-14 |
2009-03-03 |
Illumina, Inc. |
Image processing in microsphere arrays
|
|
WO2003103602A2
(en)
*
|
2002-06-11 |
2003-12-18 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
US20060247216A1
(en)
*
|
2002-10-25 |
2006-11-02 |
Haj-Yehia Abdullah I |
Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
|
|
GB2395432B
(en)
*
|
2002-11-20 |
2005-09-14 |
Northwick Park Inst For Medica |
Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
|
|
WO2004047837A2
(en)
*
|
2002-11-22 |
2004-06-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Beta-blockers having antioxidant and nitric oxide-donor activity
|
|
US20060166894A1
(en)
*
|
2002-11-29 |
2006-07-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Ace-inhibitors having antioxidant and no-donor activity
|
|
US20070207217A1
(en)
*
|
2003-02-03 |
2007-09-06 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release CO
|
|
US7166638B2
(en)
|
2003-05-27 |
2007-01-23 |
Nicox S.A. |
Statin derivatives
|
|
US7169805B2
(en)
*
|
2003-05-28 |
2007-01-30 |
Nicox S.A. |
Captopril derivatives
|
|
ATE424199T1
(de)
|
2003-06-19 |
2009-03-15 |
Nicox Sa |
Enalapril-nitroxy-derivate und verwandte verbindungen als ace-hemmer zur behandlung von kardiovaskulären erkrankungen
|
|
JP2007502831A
(ja)
*
|
2003-08-20 |
2007-02-15 |
ニトロメッド インコーポレーティッド |
ニトロソ化およびニトロシル化心血管化合物、組成物、ならびに使用方法
|
|
BRPI0417182A
(pt)
*
|
2003-12-02 |
2007-03-06 |
Nicox Sa |
composto e/ou os enantiÈmeros, diastereoisÈmeros e sais farmaceuticamente aceitáveis do mesmo, uso do mesmo, e, composição farmacêutica
|
|
RU2006119528A
(ru)
*
|
2003-12-02 |
2008-01-10 |
Никокс С.А. (Fr) |
Нитрооксипроизводные карведилола и других бета-блокаторов в качестве антигипертензивных средств
|
|
MXPA06007678A
(es)
*
|
2004-01-05 |
2006-09-01 |
Nicox Sa |
Nitroxiderivados de prostaglandinas.
|
|
US20060014829A1
(en)
*
|
2004-07-16 |
2006-01-19 |
Nitromed, Inc. |
Methods for reducing hospitalizations related to heart failure
|
|
EP1786814B1
(en)
*
|
2004-08-25 |
2010-03-31 |
Actelion Pharmaceuticals Ltd. |
Bicyclononene derivatives as renin inhibitors
|
|
EP1814535A4
(en)
*
|
2004-11-08 |
2008-06-04 |
Nitromed Inc |
NITROSED AND NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING EYE DISEASES
|
|
US20080306041A1
(en)
*
|
2005-01-21 |
2008-12-11 |
Garvey David S |
Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
|
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
|
EP1893578A2
(en)
*
|
2005-05-27 |
2008-03-05 |
Actelion Pharmaceuticals Ltd. |
Novel piperidine carboxylic acid amide derivatives
|
|
JP2009501150A
(ja)
*
|
2005-06-29 |
2009-01-15 |
ファイザー・インク |
プロスタグランジン誘導体
|
|
US20080274171A1
(en)
*
|
2005-10-18 |
2008-11-06 |
Nicoletta Almirante |
Renin Inhibitors Nitroderivatives
|
|
GB0601394D0
(en)
|
2006-01-24 |
2006-03-01 |
Hemocorm Ltd |
Therapeutic delivery of carbon monoxide
|
|
NZ570828A
(en)
|
2006-02-02 |
2011-07-29 |
Actelion Pharmaceuticals Ltd |
Secondary amines as renin inhibitors
|
|
AU2007217980A1
(en)
*
|
2006-02-17 |
2007-08-30 |
Nitromed, Inc. |
Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
|
|
AU2007224368A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Actelion Pharmaceuticals Ltd |
New amines
|
|
JP2007275193A
(ja)
*
|
2006-04-04 |
2007-10-25 |
Fujifilm Corp |
光プローブおよび光断層画像化装置
|
|
AU2007254283A1
(en)
*
|
2006-05-16 |
2007-11-29 |
Nitromed, Inc. |
Solid dosage formulations of hydralazine compounds
|
|
RU2322972C1
(ru)
*
|
2006-09-12 |
2008-04-27 |
Илья Николаевич Медведев |
Способ профилактики тромбозов у больных артериальной гипертонией с метаболическим синдромом
|
|
TW200831079A
(en)
*
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Angiotensin II receptor antagonists
|
|
FR2921365B1
(fr)
*
|
2007-09-21 |
2012-10-12 |
Servier Lab |
Nouveaux sels d'addition d'inhibiteurs d'enzyme de conversion de l'angiotensine a des acides donneurs de no, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
CN102015682B
(zh)
*
|
2008-05-05 |
2014-07-16 |
埃科特莱茵药品有限公司 |
作为肾素抑制剂的3,4-取代的哌啶衍生物
|
|
WO2010116270A1
(en)
|
2009-04-10 |
2010-10-14 |
Pfizer Inc. |
Ep2/4 agonists
|
|
WO2011160974A2
(en)
|
2010-06-21 |
2011-12-29 |
Nicox S.A. |
Statin derivatives
|
|
US9163044B2
(en)
|
2011-04-19 |
2015-10-20 |
Alfama, Inc. |
Carbon monoxide releasing molecules and uses thereof
|
|
ES2628634T3
(es)
|
2011-07-21 |
2017-08-03 |
Alfama, Inc. |
Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
|
|
CA2897571C
(en)
|
2013-01-21 |
2018-12-18 |
Apparao Satyam |
Nitric oxide releasing prodrugs of therapeutic agents containing at least one carboxylic acid group
|
|
MX2019005321A
(es)
|
2016-11-08 |
2019-10-14 |
Bausch & Lomb |
Derivados de prostaglandina que liberan oxido nitrico para el tratamiento de glaucoma de tension normal.
|
|
AU2020300002A1
(en)
|
2019-07-01 |
2022-02-24 |
Tonix Pharma Limited |
Anti-CD154 antibodies and uses thereof
|
|
US20240059781A1
(en)
|
2021-01-06 |
2024-02-22 |
Tonix Pharma Limited |
Methods of inducing immune tolerance with modified anti-cd154 antibodies
|
|
CN118146175A
(zh)
*
|
2024-02-07 |
2024-06-07 |
广州楷石生物科技有限公司 |
右旋噻吗洛尔衍生物及其制备方法和应用
|
|
WO2025248134A1
(en)
|
2024-05-31 |
2025-12-04 |
Tonix Pharma Limited |
Treatment methods comprising administration of modified cd154 antibodies
|